Nicholas W. Morrell

1994–2025 年に発表

別表記
Nicholas, W. Morrell
175
論文数
30,977
被引用数
94
h 指数
171
i10 指数

被引用数

Nicholas W. Morrell の年別被引用数1960 年: 被引用 1 件1997 年: 被引用 2 件1998 年: 被引用 9 件1999 年: 被引用 13 件2000 年: 被引用 12 件2001 年: 被引用 27 件2002 年: 被引用 51 件2003 年: 被引用 58 件2004 年: 被引用 94 件2005 年: 被引用 106 件2006 年: 被引用 152 件2007 年: 被引用 137 件2008 年: 被引用 178 件2009 年: 被引用 204 件2010 年: 被引用 198 件2011 年: 被引用 214 件2012 年: 被引用 254 件2013 年: 被引用 307 件2014 年: 被引用 258 件2015 年: 被引用 250 件2016 年: 被引用 261 件2017 年: 被引用 248 件2018 年: 被引用 321 件2019 年: 被引用 956 件2020 年: 被引用 1,383 件2021 年: 被引用 1,269 件2022 年: 被引用 1,107 件2023 年: 被引用 794 件2024 年: 被引用 1,266 件2025 年: 被引用 561 件2026 年: 被引用 11 件1961〜1996 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,719 件、この内訳の 23.7%中国: 引用元論文 1,400 件、この内訳の 12.2%イギリス: 引用元論文 1,203 件、この内訳の 10.5%ドイツ: 引用元論文 725 件、この内訳の 6.3%フランス: 引用元論文 594 件、この内訳の 5.2%カナダ: 引用元論文 470 件、この内訳の 4.1%オランダ: 引用元論文 426 件、この内訳の 3.7%イタリア: 引用元論文 323 件、この内訳の 2.8%日本: 引用元論文 276 件、この内訳の 2.4%オーストラリア: 引用元論文 268 件、この内訳の 2.4%スペイン: 引用元論文 243 件、この内訳の 2.1%スウェーデン: 引用元論文 209 件、この内訳の 1.8%
0%23.7%その他 22.8%

分野

  • Medicine63.6%
  • Biochemistry, Genetics and Molecular Biology29.9%
  • Immunology and Microbiology2.8%
  • Neuroscience1.1%
  • Chemistry0.6%
  • Engineering0.4%
  • その他1.6%

トピック

  • Pulmonary Hypertension Research and Treatments14.5%
  • Genetic Associations and Epidemiology2.2%
  • MicroRNA in disease regulation2.1%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis1.9%
  • Cardiovascular Function and Risk Factors1.7%
  • Vascular Anomalies and Treatments1.7%
  • その他75.9%

共著者

全論文

検索で開く
  1. Genomic atlas of the human plasma proteome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Danesh, Heiko Runz, Adam S. Butterworth - Nature, Nat. 2018 被引用: 2,468

  2. Whole-genome sequencing of patients with rare diseases in a national health system

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hugh S. Markus, Joannella Morales, Nicholas W. Morrell, Andrew Mumford, Elizabeth Ormondroyd, Stuart Rankin, Augusto Rendon, Sylvia Richardson, Irene Roberts, Noémi Roy, Moin A. Saleem, Kenneth G. C. Smith, Hannah Stark, Rhea Tan, Andreas C. Themistocleous, Adrian J. Thrasher, Hugh Watkins, Andrew R. Webster, Martin R. Wilkins, Catherine Williamson, James Whitworth, Sean Humphray, David R. Bentley, NIHR BioResource for the 100,000 Genomes Project, Stephen Abbs, Lara Abulhoul, Julian Adlard, Munaza Ahmed, Timothy J. Aitman, Hana Alachkar, David Allsup, J. P. Almeida, Philip Ancliff, Richard Antrobus, Ruth Armstrong, Gavin Arno, Sofie Ashford, William J. Astle, Anthony Attwood, Paul Aurora, Christian Babbs, Chiara Bacchelli, Tamam Bakchoul, Siddharth Banka, Tadbir K. Bariana, Julian Barwell, Joana Batista, Helen Baxendale, Phil Beales, David Bennett, David R. Bentley, Agnieszka Bierżyńska, Tina Biss, Maria Bitner‐Glindzicz, Graeme C. Black, Marta Bleda, Iulia Blesneac, Detlef Böckenhauer, Harm Jan Bogaard, Christian Bourne, Sara Boyce, John R. Bradley, Eugene Bragin, Gerome Breen, Paul Brennan, Carole Brewer, Matthew A. Brown, Andrew C. Browning, Michael J. Browning, Rachel Buchan ほか 412 名 - Nature, Nat. 2020 被引用: 582

  3. Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension

    著者: , , , , , , , , , , , , , - Circulation 2010 被引用: 807

  4. Genetics and genomics of pulmonary arterial hypertension

    著者: , , , , , , , - European Respiratory Journal 2018 被引用: 468

  5. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension

    著者: , , , , , , , , , , , , , , , - Nature Medicine 2015 被引用: 505

  6. Molecular genetic framework underlying pulmonary arterial hypertension

    著者: , , , - Nature Reviews Cardiology 2019 被引用: 317

  7. Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2

    著者: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2017 被引用: 262

  8. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 被引用: 451

  9. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis

    著者: , , , , , , , , , , , , , , , , , - Circulation 2017 被引用: 249

  10. BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension

    著者: , , - Circulation Research 2023 被引用: 112

  11. Cellular and molecular pathobiology of pulmonary arterial hypertension

    著者: , , , , , , , , , , - Journal of the American College of Cardiology 2004 被引用: 1,564

  12. Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension

    著者: , , , , , , , , , , , , , , , , , , - Circulation 2013 被引用: 562

  13. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2019 被引用: 432

  14. Germline selection shapes human mitochondrial DNA diversity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Catherine Williamson, NIHR BioResource–Rare Diseases, 100,000 Genomes Project–Rare Diseases Pilot, Sofie Ashford, Christopher J. Penkett, Kathleen Stirrups, Augusto Rendon, Willem H. Ouwehand, John R. Bradley, F. Lucy Raymond, Mark Caulfield, Ernest Turro, Patrick F. Chinnery, Aarnoud Huissoon, Abigail Crisp-Hihn, Adam Shaw, Adam J. Mead, Adam P. Levine, Adrian J. Thrasher, Agnieszka Bierżyńska, Ahamad Hassan, Ajith Kumar, Alba Sanchis‐Juan, Alex Richter, Allan Lawrie, Amy Frary, Andrea H. Németh, Andrea Olschewski, Andreas C. Themistocleous, Andrew C. Browning, Andrew Mumford, Andrew M. Schaefer, Andrew Marshall, Andrew O.M. Wilkie, Andrew Peacock, Andrew R. Harper, Andrew R. Webster, Andrew S.C. Rice, Angela Pyle, Ania Koziell, Anna M. Drazyk, Anne M. Kelly, Annette Wagner, Anthony Attwood, Anthony De Soyza, Anthony M. Vandersteen, Anthony T. Moore, Anton Vonk Noordegraaf, Anupama Rao, Archana Herwadkar, Arjan C. Houweling, Arjune Sen, Augusto Rendon, Austen Worth, Barbara Girerd, Bella Madan, Brian T. Wilson, Carmen Bugarin Diz, Carmen Treacy, Carole Brewer, Carolyn Campbell, Carolyn M. Millar, Catherine Roughley, Catherine Titterton, Catherine Williamson, Cecilia Compton, Cesare Danesino, Chantal Thys, Charaka Hadinnapola, Charu Deshpande ほか 305 名 - Science 2019 被引用: 251

  15. TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling

    著者: , , , , , , , , , , , , , , - Nature Communications 2017 被引用: 230

  16. Primary Pulmonary Hypertension Is Associated With Reduced Pulmonary Vascular Expression of Type II Bone Morphogenetic Protein Receptor

    著者: , , , , , , - Circulation 2002 被引用: 684

  17. Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension

    著者: , , , , , , , , , , , , , , , , , , , , - Circulation 2016 被引用: 217

  18. Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Research 2021 被引用: 143

  19. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Girerd, Arjan C. Houweling, Luke Howard, Marc Humbert, David G. Kiely, Gábor Kovács, Robert V. MacKenzie Ross, Shahin Moledina, David Montani, Michael Newnham, Andrea Olschewski, Horst Olschewski, Andrew J. Peacock, Joanna Pepke‐Żaba, Inga Prokopenko, Christopher J. Rhodes, Laura Scelsi, Werner Seeger, Florent Soubrier, Dan F. Stein, Jay Suntharalingam, Emilia M. Swietlik, Mark Toshner, David A. van Heel, Anton Vonk Noordegraaf, Quinten Waisfisz, John Wharton, Stephen J. Wort, Willem H. Ouwehand, Nicole Soranzo, Allan Lawrie, Paul D. Upton, Martin R. Wilkins, Richard C. Trembath, Nicholas W. Morrell - Nature Communications 2018 被引用: 384

  20. Chloroquine Prevents Progression of Experimental Pulmonary Hypertension via Inhibition of Autophagy and Lysosomal Bone Morphogenetic Protein Type II Receptor Degradation

    著者: , , , , , , - Circulation Research 2013 被引用: 284

  21. HIF2α–arginase axis is essential for the development of pulmonary hypertension

    著者: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 被引用: 183

  22. Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension

    著者: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2021 被引用: 81

  23. Cellular and Molecular Basis of Pulmonary Arterial Hypertension

    著者: , , , , , , , , , , , - Journal of the American College of Cardiology 2009 被引用: 812

  24. Inflammation, Growth Factors, and Pulmonary Vascular Remodeling

    著者: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2009 被引用: 720